Sabra Healthcare REIT (SBRA) Projected to Post Earnings on Wednesday

Sabra Healthcare REIT (NASDAQ:SBRA) is projected to release its Q1 2026 results after the market closes on Wednesday, April 29th. Analysts expect Sabra Healthcare REIT to post earnings of $0.1627 per share and revenue of $204.5340 million for the quarter. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Interested persons can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, April 30, 2026 at 1:00 PM ET.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period last year, the firm posted $0.36 EPS. On average, analysts expect Sabra Healthcare REIT to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Healthcare REIT Trading Down 2.0%

NASDAQ:SBRA opened at $20.09 on Wednesday. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The firm has a market capitalization of $5.07 billion, a price-to-earnings ratio of 31.39, a price-to-earnings-growth ratio of 1.64 and a beta of 0.67. Sabra Healthcare REIT has a one year low of $17.04 and a one year high of $21.07. The business has a fifty day moving average price of $20.22 and a 200-day moving average price of $19.24.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is 187.50%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the business. Smartleaf Asset Management LLC boosted its stake in shares of Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares in the last quarter. Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT during the third quarter worth $30,000. Larson Financial Group LLC lifted its stake in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after buying an additional 1,536 shares during the period. Finally, Quarry LP acquired a new stake in shares of Sabra Healthcare REIT during the third quarter worth $48,000. 99.40% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on SBRA. Scotiabank upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd. Citizens Jmp increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. UBS Group increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, February 19th. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Finally, Cantor Fitzgerald upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average target price of $22.00.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.